Filter By Category

Insights

Why We Need Innovative Nuclear Energy

Intellectual Ventures founder and CEO Nathan Myhrvold illuminates why people and the planet need every source of reliable, carbon-free energy we can get.

Read More

Insights

Why We’re Reinventing the Door and Window

A new study by Global Good and its partners explores how reinventing two common household items—the window and door—could save lives by keeping pesky mosquitoes out of African homes.

Read More

Insights

Founder and CEO Nathan Myhrvold Upends Asteroid Assumptions in New Study

In a new study published in the journal Icarus, Nathan argues that astronomers don’t have as good a handle on the size and other physical characteristics of asteroids as they previously thought.

Read More

Insights

Intellectual Ventures Develops the First Offline Virtual Malaria Microscopy Training Course

The World Health Organization-approved eLearning tool can be used regardless of Internet access.

Read More

Press Releases

Access Bio and Global Good collaborate for five-fold improvement in pLDH marker detection for HRP2-deleted P. falciparum

New, high-impact detection kit will prove useful for both P. falciparum and P. vivax species.

Read More

Press Releases

Intellectual Ventures Reaches Settlement, License Agreement with HCC

“With this license, we are one step closer to ending the unlicensed use of our technology by the insurance industry,” said Mathen Ganesan, executive vice president, Invention Investment Fund at Intellectual Ventures.

Read More

Press Releases

AI approach outperformed human experts in identifying cervical precancer

Algorithm could revolutionize cervical cancer screening, especially in low-resource settings.

Read More

Press Releases

JP Selecta, Global Good Collaboration Brings Novel Microbiology Incubator to Market

Microbiologists now have ability to adequately conduct microbiological tests in laboratories with unreliable access to power.

Read More

Publications

New Prototype Screened Doors and Windows for Excluding Mosquitoes from Houses: A Pilot Study in Rural Gambia.

With partners, Global Good is redesigning the window and door to keep deadly mosquitoes out of African homes.

Read More

Publications

Automated microscopy for routine malaria diagnosis: a field comparison on Giemsa-stained blood films in Peru.

Autoscope was tested in the Iquitos region of Peru in 2016 at two peripheral health facilities, with routine microscopy and PCR as reference standards. The main outcome measures include sensitivity and specificity of diagnosis of malaria from Giemsa-stained blood films, using PCR as reference.

Read More

Publications

Polydisperse emulsion digital assay to enhance time to detection and extend dynamic range in bacterial cultures enabled by a statistical framework.

Microbiological culture remains the most sensitive method for detecting viable and infectious bacteria, but these methods often require at least 24 hours to visibly identify bacterial growth.

Read More

Publications

Improving Lateral Flow Assay Performance Using Computational Modeling.

Here, we review the principles underpinning lateral flow assays and the historical evolution of theory to predict their performance.

Read More

Media Coverage

EarthNow fleshes out plan to deliver video that shows Earth from orbit in real time

GeekWire

EarthNow announced exciting new updates in its mission to establish high-res, real time video from space. The IV spinout hopes to launch its first satellite by 2020.

Read More

Media Coverage

One Way to Finance Tech Startups Outside of Superstar Cities

Harvard Business Review

IV co-founder Edward Jung was in Harvard Business Review for contributing a piece on Local Innovation Bonds and different ways to invest in tech startups.

Read More

Media Coverage

Innovator of the Month: Modern Electron lights the way to generate electricity inside your home

Puget Sound Business Journal

Tony Pan, co-founder and CEO of IV spinout Modern Electron, was named Puget Sound Business Journal’s Innovator of the Month this December. 

Read More

Media Coverage

Bellevue research scientist is on a mission to improve global health equality

The Seattle Times

IV research scientist Corrie Ortega shares her background and what her experience at IV has been like in this Seattle Times Q&A.

Read More

Popular Tags

inventors invention global good nathan myhrvold stem iv lab secondary market patent reform licensing historical adriane brown global health u.s. economy invention science fund litigation edward jung commercialization patent policy portfolio partner idf c-suite customer asia